key: cord-0755945-cwbqo2fh
authors: Cassaniti, Irene; Percivalle, Elena; Zelini, Paola; Nanhorngue, Kimta Ngaradoumbe; Parolo, Anna; Bernardi, Valeria; Jorizzo, Gianfranco; Santer, Peter; Perotti, Francesca; Spinillo, Arsenio; Lilleri, Daniele; Baldanti, Fausto
title: Both SARS-CoV-2 infection and vaccination in pregnancy elicited neutralizing antibodies in pregnant women and newborns
date: 2021-08-08
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2021.08.004
sha: 404c0c524da32276f9058fbbde02b84ec3c695d2
doc_id: 755945
cord_uid: cwbqo2fh

nan

To the Editor.

To date, few data on SARS-CoV-2 immune response after infection or vaccination have been reported 23 in pregnant women. So far, maternal immunization during pregnancy inducing trans-placental 24 antibody transfer to the newborn is currently supported to reduce morbidity and mortality from 25 infectious diseases after birth. 26 After having signed written informed consent, two healthcare workers received complete Spike-specific IgG were detectable in N#1 and N#2 (8.0 and 5.4) at higher levels than in VM#1 and 37 VM#2 (6.8 and 4.0), with a newborn-to-maternal serum ratio of 1.2 and 1.4, respectively. As control, 38 the newborn-to-maternal serum ratio for anti-cytomegalovirus (CMV) IgG measured by ELISA 39 (Euroimmun) was 1.0 and 1.3. The neutralizing (NT) antibody titer [1] was higher in VW#2 than Table 1 and Supplementary Table 1 .

Current data suggest that pregnant women may be at increased risk to be admitted to an 51 intensive care unit with respect to non-pregnant women, thus vaccination might represent a valuable 52 preventive strategy. 

Prevalence of SARS-CoV-2 specific neutralising 97 antibodies in blood donors from the Lodi Red Zone

Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the 101 COVID-19 Pandemic

Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios

COVID-19 vaccine response in pregnant and lactating 105 women: a cohort study

Compromised SARS-CoV-2-specific placental antibody 107 transfer

Efficient maternofetal transplacental 109 transfer of anti-SARS-CoV-2 spike antibodies after antenatal SARS-CoV-2 BNT162b2 110 mRNA vaccination